An observational study in COVID19, sponsored by Instituto Costarricense de Investigaciones Clínicas ICIC. Withdrawn at 1 site in Costa Rica. Open to participants aged 7 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-11-29.
Sponsored by Instituto Costarricense de Investigaciones Clínicas ICIC · Observational
The purpose of the study is to verify the sensibility and accuracy of a rapid detection test for SARS-CoV-2 in breath samples analyzed by the breath detector analyzer TeraSystem, comparing with PCR tests.
BioSafety Technologies has developed a rapid detection test to clear people of COVID-19.
A person can undergo an easy non-invasive test, to determine if they are: COVID-19 Clear (Negative) or Infected (Positive). The user-friendly process does not involve medically trained personnel.
The study will compare TeraSystem test results against PCR test results. Persons participating will be persons having a PCR test as part of the Health System and consenting to participate.
7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.
Browse COVID-19 studies →This is the only study on the registry with Instituto Costarricense de Investigaciones Clínicas ICIC as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Population under Country's screening program and known positive cases.
Older than 7 years odf age Able to provide informed consent Able to take the breath test
Exclusion Criteria:
Younger than 7 years of age Unable to provide informed consent Unable to take the breath test
Patients having positive PCR tests will undergo TeraSystem test
Diagnostic Test: Breath sample
Patients having negative PCR tests will undergo TeraSystem test
Diagnostic Test: Breath sample
Patient will blow into a tube 5 times.
Presence of disease
Established diagnosis
Time frame: 1 minute
Plan to share: No — Personal data will be coded. No identifying information will be shared. Only demographic, and breath tests results will be shared.
No publications or documents are linked to this record.
This study is withdrawn, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.